A perfusion bioreactor system efficiently generates cell-loaded bone substitute materials for addressing critical...

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Tissue Engineering

Background:

• Critical size bone defects and non-union fractures present significant clinical challenges.
• Cell-loaded bone substitutes enhance bone ingrowth but face limitations in scaffold colonization and cell population homogeneity.
• Current methods struggle to produce large-volume bone grafts with consistent cell distribution.

Purpose of the Study:

• To develop a technology for generating large bone grafts (10.5 mm diameter, 25 mm height) suitable for critical size bone defects.
• To establish standardized conditions for cell colonization and osteogenic differentiation of bone substitutes.
• To overcome limitations in homogeneous cell distribution and therapy robustness in bone grafting.

Main Methods:

• Development of a novel, tailor-made bioreactor system for standardized flow conditions.
• Utilizing porous poly(L-lactide-co-caprolactone) scaffolds seeded with primary human mesenchymal stem cells from multiple donors.
• Comparison of dynamic culture conditions in the bioreactor versus static culture.

Main Results:

• Homogeneous cell distribution within scaffolds was achieved under dynamic culture conditions, unlike static methods.
• Osteogenic lineage commitment was induced within one week of culture without soluble factors.
• Quantitative analysis confirmed calcification and expression of osteogenic gene markers.

Conclusions:

• The novel bioreactor technology enables efficient and standardized generation of bone substitutes.
• The developed bone grafts are suitable for treating critical size bone defects in humans.
• This advancement offers a robust solution for creating large, cell-homogenized bone grafts.